{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:38:48Z","timestamp":1788057528668,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109403","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:37:06Z","timestamp":1752575826000},"page":"109403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6\u00a0months of therapy: A narrative review"],"prefix":"10.1016","volume":"253","author":[{"given":"Andrea","family":"Boccatonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Simion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Brighenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109403_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.thromres.2017.05.015","article-title":"Venous thromboembolism in the elderly: a narrative review","volume":"155","author":"Tritschler","year":"2017","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2024.104246","article-title":"Elderly patients with venous thromboembolism: insights from the RIETE registry","volume":"53","author":"Mismetti","year":"2024","journal-title":"Presse Med."},{"issue":"11","key":"10.1016\/j.thromres.2025.109403_bb0015","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/17474086.2018.1526667","article-title":"The prevention of venous thromboembolism recurrence in the elderly: a still open issue","volume":"11","author":"Palareti","year":"2018","journal-title":"Expert Rev. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109403_bb0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/ggi.13118","article-title":"Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society","volume":"17","author":"Ouchi","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"issue":"5","key":"10.1016\/j.thromres.2025.109403_bb0025","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1160\/TH08-04-0255","article-title":"Venous thromboembolism in the elderly. A community-based perspective","volume":"100","author":"Spencer","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2014.02.011","article-title":"Venous thromboembolism in older adults: a community-based study","volume":"127","author":"Spencer","year":"2014","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0035","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH08-12-0827","article-title":"Venous thromboembolism in nonagenarians. Findings from the RIETE registry","volume":"101","author":"Vasco","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109403_bb0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2025.109403_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2019.08.024","article-title":"Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: results from the prospective multicenter START2-Register Study","volume":"183","author":"Poli","year":"2019","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2025.109403_bb0050","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jgs.16549","article-title":"DOACs versus VKAs in older adults treated for acute venous thromboembolism: systematic review and meta-analysis","volume":"68","author":"Chaudhary","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"10.1016\/j.thromres.2025.109403_bb0055","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109403_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/bloodadvances.2022007263","article-title":"Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism","volume":"7","author":"Ferrazzini","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109403_bb0065","article-title":"The impact of preinjury antiplatelet and anticoagulant use on elderly patients with moderate or severe traumatic brain injury following traumatic acute subdural hematoma","volume":"166","author":"O\u2019Donohoe","year":"2022","journal-title":"World Neurosurg."},{"issue":"2","key":"10.1016\/j.thromres.2025.109403_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1358863X14566429","article-title":"Venous thromboembolism: predicting recurrence and the need for extended anticoagulation","volume":"20","author":"Barnes","year":"2015","journal-title":"Vasc. Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109403_bb0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-0039-1679906","article-title":"Long-term management of venous thromboembolism: lessons from EINSTEIN CHOICE and other extension trials","volume":"119","author":"Weitz","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0080","first-page":"49","article-title":"Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study","volume":"18","author":"Imberti","year":"2020","journal-title":"Blood Transfus."},{"issue":"19","key":"10.1016\/j.thromres.2025.109403_bb0085","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0090","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2025.109403_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","article-title":"D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study","volume":"124","author":"Palareti","year":"2014","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.thromres.2025.109403_bb0100","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1182\/bloodadvances.2022007973","article-title":"D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study","volume":"6","author":"Palareti","year":"2022","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.thromres.2025.109403_bb0105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/gerona\/glu240","article-title":"Prevalence of hereditary thrombophilia in patients older than 75 years with venous thromboembolism referred for thrombophilia screening","volume":"70","author":"Siguret","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11739-021-02765-1","article-title":"Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study","volume":"17","author":"Palareti","year":"2022","journal-title":"Intern. Emerg. Med."},{"issue":"13","key":"10.1016\/j.thromres.2025.109403_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024425","article-title":"Extended anticoagulation after pulmonary embolism: a multicenter observational cohort analysis","volume":"11","author":"Chopard","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.thromres.2025.109403_bb0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11239-020-02274-6","article-title":"Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE","volume":"51","author":"G\u00f3mez-Cuervo","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"14","key":"10.1016\/j.thromres.2025.109403_bb0130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"de Winter","year":"2023","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.thromres.2025.109403_bb0135","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1055\/s-0041-1726345","article-title":"Comparison of bleeding risk scores in elderly patients receiving extended anticoagulation with vitamin K antagonists for venous thromboembolism","volume":"121","author":"Frei","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109403_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2016.03.028","article-title":"Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: a multi-national cohort","volume":"143","author":"Rodger","year":"2016","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurheartj\/ehad618","article-title":"The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study","volume":"45","author":"Kyrle","year":"2024","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109403_bb0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.thromres.2018.07.020","article-title":"\u201cHERDOO2\u201d clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-dimer?","volume":"169","author":"Rodger","year":"2018","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109403_bb0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCP.0b013e328363ed7c","article-title":"Assessing recurrence risk following acute venous thromboembolism: use of algorithms","volume":"19","author":"Poli","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"10","key":"10.1016\/j.thromres.2025.109403_bb0165","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.209924","article-title":"Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study","volume":"104","author":"Cate","year":"2019","journal-title":"Haematologica"},{"issue":"10480","key":"10.1016\/j.thromres.2025.109403_bb0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.thromres.2025.109403_bb0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.thromres.2025.109403_bb0180","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12325-023-02717-5","article-title":"Efficacy and safety of different doses of rivaroxaban and risk factors for bleeding in elderly patients with venous thromboembolism: a real-world, multicenter, observational, cohort study","volume":"41","author":"Lu","year":"2024","journal-title":"Adv. Ther."},{"issue":"5","key":"10.1016\/j.thromres.2025.109403_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40266-025-01192-7","article-title":"Benefit-risk assessment of rivaroxaban in older patients with nonvalvular atrial fibrillation or venous thromboembolism","volume":"42","author":"Dobesh","year":"2025","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/cts.12876","article-title":"Edoxaban for the long-term therapy of venous thromboembolism: should the criteria for dose reduction be revised?","volume":"14","author":"Camporese","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/15385744241253201","article-title":"Efficacy and safety of direct Oral anticoagulants for acute treatment of venous thromboembolism in older adults: a network meta-analysis of randomised controlled trials","volume":"58","author":"Pess\u00f4a","year":"2024","journal-title":"Vasc. Endovascular Surg."},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.thromres.2025.109403_bb0210","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.115.016930","article-title":"Sulodexide for the prevention of recurrent venous thromboembolism: the sulodexide in secondary prevention of recurrent deep vein thrombosis (SURVET) study: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"132","author":"Andreozzi","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2025.109403_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11739-020-02381-5","article-title":"Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism","volume":"16","author":"Palareti","year":"2021","journal-title":"Intern. Emerg. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40266-023-01085-7","article-title":"Do proton pump inhibitors reduce upper gastrointestinal bleeding in older patients with atrial fibrillation treated with oral anticoagulants? A nationwide cohort study in France","volume":"41","author":"Drusch","year":"2024","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0225","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.thromres.2025.109403_bb0230","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/jgs.16400","article-title":"Prevalence and severity of traumatic intracranial hemorrhage in older adults with low-energy falls","volume":"68","author":"Lampart","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.thromres.2025.109403_bb0235","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/STROKEAHA.122.041628","article-title":"Clinical outcomes of anticoagulated patients with atrial fibrillation after falls or head injury: insights from RE-LY","volume":"54","author":"Caldeira","year":"2023","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.thromres.2025.109403_bb0240","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40266-021-00870-6","article-title":"Impact of fall risk and direct oral anticoagulant treatment on quality-adjusted life-years in older adults with atrial fibrillation: a Markov decision analysis","volume":"38","author":"Wei","year":"2021","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s41999-023-00811-z","article-title":"Anticoagulant use in older persons at risk for falls: therapeutic dilemmas-a clinical review","volume":"14","author":"Mitchell","year":"2023","journal-title":"Eur. Geriatr. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109403_bb0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13049-021-00866-6","article-title":"Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?","volume":"29","author":"M\u00fcller","year":"2021","journal-title":"Scand. J. Trauma Resusc. Emerg. Med."},{"key":"10.1016\/j.thromres.2025.109403_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2024.04.009","article-title":"Oral anticoagulant therapy in older adults","volume":"238","author":"Stuby","year":"2024","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109403_bb0260","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.jtha.2024.05.007","article-title":"Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism","volume":"22","author":"Gabara","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2025.109403_bb0265","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/17474086.2023.2288154","article-title":"Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection","volume":"16","author":"Boccatonda","year":"2023","journal-title":"Expert Rev. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109403_bb0270","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1055\/s-0042-1758869","article-title":"The journey through the pathogenesis and treatment of venous thromboembolism in inflammatory bowel diseases: a narrative review","volume":"49","author":"Boccatonda","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109403_bb0275","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2024.04.023","article-title":"DOACs for older adults with atrial fibrillation and falls: results from the prospective single-centre DOAFF study","volume":"238","author":"Catalani","year":"2024","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109403_bb0280","article-title":"Platelet, antiplatelet therapy and metabolic dysfunction-associated steatotic liver disease: a narrative review","volume":"14","author":"Boccatonda","year":"2024","journal-title":"Life (Basel)"},{"issue":"7","key":"10.1016\/j.thromres.2025.109403_bb0285","doi-asserted-by":"crossref","first-page":"949","DOI":"10.7326\/M22-3559","article-title":"Indefinite anticoagulant therapy for first unprovoked venous thromboembolism\u202f: a cost-effectiveness study","volume":"176","author":"Khan","year":"2023","journal-title":"Ann. Intern. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:28:51Z","timestamp":1761406131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"alternative-id":["S0049384825001537"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109403","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6\u00a0months of therapy: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109403"}}